Amgen reports efficacy of Prolia in increasing bone mineral density
Prolia is a therapy for the treatment of postmenopausal women with osteoporosis that specifically targets RANK Ligand, an essential regulator of osteoclasts. The treatment over three years led
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.